biguanides has been researched along with Psychotic Disorders in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kar, SK | 1 |
| Shahi, MK | 1 |
| Roy, P | 1 |
| Hayes, JF | 1 |
| Lundin, A | 1 |
| Wicks, S | 1 |
| Lewis, G | 1 |
| Wong, ICK | 1 |
| Osborn, DPJ | 1 |
| Dalman, C | 1 |
2 other studies available for biguanides and Psychotic Disorders
| Article | Year |
|---|---|
Understanding the anxiety phenomenology in psychotic prodrome: A case report.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Biguanides; Clonazepam; Drug Therapy, Combinatio | 2017 |
Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness.
Topics: Biguanides; Bipolar Disorder; Calcium Channel Blockers; Female; Hospitalization; Humans; Hydroxymeth | 2019 |